LanzaTech Global, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that LanzaTech Global, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $49.59M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $62.63M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $37.34M | Feb 29, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($137.73M) | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | ($134.10M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($76.36M) | Feb 29, 2024 |
| FY2021 | Dec 31, 2021 | $46.7K | Mar 25, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($108.93M) | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | ($106.38M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | ($75.60M) | Feb 29, 2024 |
| FY2021 | Dec 31, 2021 | ($1.39M) | Mar 25, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $174.68M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $241.62M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $176.86M | Feb 29, 2024 |
| FY2021 | Dec 31, 2021 | $150.87M | Mar 25, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $161.24M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $127.15M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $124.95M | Feb 29, 2024 |
| FY2021 | Dec 31, 2021 | $11.61M | Mar 25, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $13.45M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $114.47M | Apr 15, 2025 |
| FY2024 | Dec 31, 2022 | ($428.72M) | Apr 15, 2025 |
| FY2023 | Dec 31, 2021 | ($354.92M) | Feb 29, 2024 |
| FY2021 | Jan 27, 2021 | $0 | Mar 25, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (12) | Feb 29, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 0 | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | 0 | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | (12) | Feb 29, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $43.50M | Apr 15, 2025 |
| FY2024 | Dec 31, 2023 | $75.59M | Apr 15, 2025 |
| FY2023 | Dec 31, 2022 | $83.05M | Feb 29, 2024 |
| FY2021 | Dec 31, 2021 | $343.4K | Mar 25, 2022 |